Inventor
MEYER KRISTA
US5 patents
Patents
5 patentsUS10007766B2Jun 26, 2018
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC9 citations81
US10950348B2Mar 16, 2021
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC2 citations70
US11710539B2Jul 25, 2023
Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy
BIODESIX INC1 citations60
US11621057B2Apr 4, 2023
Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy
BIODESIX INC1 citations60
US12230398B2Feb 18, 2025
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC0 citations56